License and Collaborative Agreements (Details) (USD $)	12 Months Ended				1 Months Ended	12 Months Ended
	Dec. 31, 2013 Hitachi Chemical Co., Ltd. [Member] Collaborative Arrangement [Member]	Dec. 31, 2012 Hitachi Chemical Co., Ltd. [Member] Collaborative Arrangement [Member]	Dec. 31, 2013 Shanghai BioChip Company, Ltd. [Member] Collaborative Arrangement [Member]	Dec. 31, 2012 Shanghai BioChip Company, Ltd. [Member] Collaborative Arrangement [Member]	Mar. 31, 2010 Licensing Agreements [Member]	Dec. 31, 2013 Licensing Agreements [Member] University of Southern California [Member]	Dec. 31, 2012 Licensing Agreements [Member] University of Southern California [Member]	Dec. 31, 2013 Licensing Agreements [Member] Roche Molecular Systems [Member]	Dec. 31, 2012 Licensing Agreements [Member] Roche Molecular Systems [Member]	Dec. 31, 2013 Licensing Agreements [Member] GlaxoSmithKline, LLC [Member]	Dec. 31, 2012 Licensing Agreements [Member] GlaxoSmithKline, LLC [Member]	Dec. 31, 2013 Service Agreements [Member] Taiho Pharmaceutical Co., Ltd. [Member]	Dec. 31, 2012 Service Agreements [Member] Taiho Pharmaceutical Co., Ltd. [Member]	Dec. 31, 2013 Service Agreements [Member] GlaxoSmithKline, LLC [Member]	Dec. 31, 2012 Service Agreements [Member] GlaxoSmithKline, LLC [Member]	Dec. 31, 2013 Service Agreements [Member] GSK Bio [Member]	Dec. 31, 2012 Service Agreements [Member] GSK Bio [Member]
License and Collaborative Agreements [Line Items]
Royalty expense included in cost of revenue						$ 305,616	$ 332,504	$ 280,325	$ 336,285
Revenue recognized	0	526,823	35,027	15,355								950,000	1,193,425	1,134,366	1,280,704	3,534,619	3,241,211
Milestone payment received										1,000,000	500,000
Collaborative agreement, optional additional period														1 year
Collaborative agreement, term														2 years
Collaborative agreement, automatic renewal period	1 year
Collaborative agreement, termination notice period			90 days													90 days
Revenue Recognition Milestone Method Further Payment					$ 1,500,000